RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Choi, S. R. [1 ]
Shin, A. [1 ]
Ha, Y. J. [1 ]
Lee, Y. J. [1 ]
Lee, E. B. [2 ]
Kang, E. H. [1 ]
机构：
[1] Seoul Natl Univ, Div Rheumatol, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
[2] Seoul Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Safety; Rheumatoid arthritis; Disease-modifying drugs (DMARDs);
D O I：
10.1136/annrheumdis-2023-eular.5291
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0836
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [41] COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE "JAK-POT" STUDY)
    Lauper, K.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    De Cock, D.
    Dreyer, L.
    Elkayam, O.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kristianslund, E.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Pavelka, K.
    Pombo-Suarez, M.
    Rotar, Z.
    Santos, M. J.
    Strangfeld, A.
    Courvoisier, D.
    Finckh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 146 - 147
  • [42] Comparative effectiveness of JAK-inhibitors, TNF-inhibitors, abatacept and IL-6 inhibitors in an international collaboration of registers of rheumatoid arthritis patients (the "JAK-pot" study)
    Lauper, K.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Catalin, Codreanu
    De Cock, D.
    Lene, Dreyer
    Elkayam, O.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kristianslund, E.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Pavelka, K.
    Pombo Suarez, M.
    Rotar, Z.
    Santos, M. J.
    Strangfeld, A.
    Courvoiser, D. S.
    Finckh, A.
    SWISS MEDICAL WEEKLY, 2020, : 8S - 8S
  • [43] ASSOCIATION BETWEEN BIOACTIVE TNF AND EULAR RESPONSE TO TNF INHIBITORS IN RHEUMATOID ARTHRITIS
    Poudroux, J.
    Marotte, H.
    Gottenberg, J. -E.
    Paul, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 218 - 218
  • [44] Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
    Nakashita, Tamao
    Ando, Katsutoshi
    Kaneko, Norihiro
    Takahashi, Kazuhisa
    Motojima, Shinji
    BMJ OPEN, 2014, 4 (08):
  • [45] REPLICATION OF GWAS OF RESPONSE TO TNF INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ferreiro-Iglesias, A.
    Montes, A.
    Perez-Pampin, E.
    Carreira, P.
    Joven, B.
    Caliz, R.
    Ferrer, M. A.
    Moreno-Ramos, M. J.
    Raya, E.
    Magro, C.
    Vasilopoulos, Y.
    Sarafidou, T.
    Balsa, A.
    Pascual-Salcedo, D.
    Fernandez-Nebro, A.
    Ordonez, M. C.
    Alegre-Sancho, J. J.
    Marquez, A.
    Navarro, F.
    Moreira, V.
    Blanco, F. J.
    Narvaez, J.
    Canete, J. D.
    Martin, J.
    Gomez-Reino, J. J.
    Gonzalez, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 115 - 115
  • [46] DRUG SURVIVAL ON TNF INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN FINLAND
    Aaltonen, K. J.
    Joensuu, J.
    Pirila, L.
    Kauppi, M.
    Uutela, T.
    Varjolahti-Lehtinen, T.
    Yli-Kerttula, T.
    Isomaki, P.
    Nordstrom, D.
    Sokka, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 500 - 500
  • [47] Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated with JAK Inhibitors and TNF Inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study
    Cho, Yongtai
    Yoon, Dongwon
    Khosrow-Khavar, Farzin
    Song, Minkyo
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 9 - 9
  • [48] Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment
    Haridoss, Madhumitha
    Sasidharan, Akhil
    Kumar, Sajith
    Rajsekar, Kavitha
    Venkataraman, Krishnamurthy
    Bagepally, Bhavani Shankara
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2024, 22 (06) : 885 - 896
  • [49] Discontinuation of TNFα inhibitors in rheumatoid arthritis and psoriatic arthritis
    Oskarsdottir, Thorunn
    Gunnarsdottir, Anna Ingibjorg
    Gudbjornsson, Bjorn
    Gunnarsson, Petur Sigurdur
    Love, Thorvardur
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 182 - 183
  • [50] EFFECT OF JAK INHIBITORS ON PAIN AND QUALITY OF LIFE IN RHEUMATOID ARTHRITIS PATIENTS
    Spinelli, F. R.
    Garufi, C.
    Ceccarelli, F.
    Mancuso, S.
    Duca, I.
    Alessandri, C.
    Di Franco, M.
    Priori, R.
    Riccieri, V.
    Scrivo, R.
    Valesini, G.
    Conti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 645 - 645
12345